OTTAWA, April 27 /CNW/ - A cancer study led by an Ottawa researcher is
among 52 new research projects worth close to $22 million announced
today by the Canadian Cancer Society.
Dr Barbara Vanderhyden of the Ottawa Hospital Research Institute has
been awarded $415,419 for her work in ovarian cancer.
"Funding excellent research to outsmart cancer is one important way the
Canadian Cancer Society fights back against the disease," says Dawn
Cooper, Manager, Ottawa Unit, Canadian Cancer Society. "We are grateful
to our generous supporters who make research such as this possible."
Dr Vanderhyden is studying the role of a unique group of cells on the
ovary that are more susceptible to becoming ovarian cancer cells, and
how they may be affected by mutations in a gene that normally suppress
tumour growth. Improved knowledge about some of the mechanisms involved
in the development of ovarian cancer could lead to improved prevention
and early detection of the disease.
"We are very pleased to receive this funding," says Dr Vanderhyden.
"Understanding how ovarian cancers begin is a most important first step
to finding methods for prevention and early detection, and my research
team and I are eager to get started on this work."
The Canadian Cancer Society is a national community-based organization
of volunteers whose mission is the eradication of cancer and the
enhancement of the quality of life of people living with cancer. When
you want to know more about cancer, visit our website www.cancer.ca or call our toll-free, bilingual Cancer Information Service at 1 888 939-3333.
SOURCE Canadian Cancer Society (Ontario Division)
For further information:
Dawn Cooper, Manager, Ottawa Unit, Canadian Cancer Society: (613) 723-1744, ext 3611; email@example.com .